Logo
  • Home
  • AI Agent
  • Annotations
  • Files
  • Pricing and plans
  • BlogAboutContact us
    APIMCP
    Terms of servicePrivacy policy
  • Get the full experience

    We save the real magic for signed-in users.

4483 JT​
HomeStock ScreenerDocument SearchChartingWatchlistsRecent Filings
Logo
  • Home
  • AI Agent
  • Annotations
  • Files
  • Pricing and plans
  • BlogAboutContact us
    APIMCP
    Terms of servicePrivacy policy
  • Get the full experience

    We save the real magic for signed-in users.

4483 JT​
HomeStock ScreenerDocument SearchChartingWatchlistsRecent Filings

JMDC Inc.(4483 JT)

$3,855.00+380.0010.94%(Market Closed · 06:30:00 UTC · (20 min delay))
ProfileFinancialsChartingEmployees

Overview

Profile

Financials & Metrics

FinancialsChartingEmployees

JMDC Inc.(4483 JT)

$3,855.00+380.0010.94%(Market Closed · 06:30:00 UTC · (20 min delay))
ProfileFinancialsChartingEmployees

Overview

Profile

Financials & Metrics

FinancialsChartingEmployees
Ask AI
Ask AI

JMDC Inc. — Company Profile

JMDC Inc. is a Japanese corporation primarily focused on delivering analytical and statistical services for the medical sector. Its operations are structured across three principal divisions: Healthcare-Big Data, Telemedicine, and Dispensing Pharmacy Support. Within the Healthcare-Big Data segment, the company provides extensive big data solutions tailored for both the medical and life insurance industries. It also offers crucial support services to health insurance associations and local government health programs, develops a robust health data platform, and aids medical institutions. The Telemedicine division facilitates remote medical imaging interpretation through specialized matching services and ASP systems. Concurrently, its Dispensing Pharmacy Support segment develops and markets bespoke business management software specifically designed for dispensing pharmacies. JMDC serves a broad spectrum of clients, including health insurance providers, pharmaceutical manufacturers, life and general insurance companies, and research organizations. The company, established in 2002, maintains its corporate headquarters in Tokyo, Japan.

Sector
Healthcare
Industry
Medical - Healthcare Information Services
Exchange
JT
CEO
Ryo Noguchi
Headquarters
Tokyo, TY, JP
IPO Date
Dec 16, 2019
Employees
2,444
Website
www.jmdc.co.jp

Key Metrics

Price
$3630.00
Market Cap
$237.56B
Revenue (TTM)
$50.46B
Net Income (TTM)
$6.76B
EPS (TTM)
103.43
P/E (TTM)
35.12
P/B (TTM)
2.84
Dividend Yield
55.73%
ROE (TTM)
8.08%
ROA (TTM)
4.27%
Operating Margin
19.78%
Beta
-0.09

Dividends

Last Dividend
$18.00
Last Yield
0.56%

Summary

JMDC Inc. is a Japanese corporation primarily focused on delivering analytical and statistical services for the medical sector. Its operations are structured across three principal divisions: Healthcare-Big Data, Telemedicine, and Dispensing Pharmacy Support. Within the Healthcare-Big Data segment, the company provides extensive big data solutions tailored for both the medical and life insurance industries. It also offers crucial support services to health insurance associations and local government health programs, develops a robust health data platform, and aids medical institutions. The Telemedicine division facilitates remote medical imaging interpretation through specialized matching services and ASP systems. Concurrently, its Dispensing Pharmacy Support segment develops and markets bespoke business management software specifically designed for dispensing pharmacies. JMDC serves a broad spectrum of clients, including health insurance providers, pharmaceutical manufacturers, life and general insurance companies, and research organizations. The company, established in 2002, maintains its corporate headquarters in Tokyo, Japan.

Website
www.jmdc.co.jp
Location
Tokyo, TY, JP
Phone81 3 5733 5010
Employees2,444
CEORyo Noguchi
SectorHealthcare
IndustryMedical - Healthcare Information Services
IPO DateDec 16, 2019

Ask AI

Company overview
Business model, segments, and competition.
Peer comparison
Metrics vs closest competitors.
Guidance & outlook
Forward guidance and assumptions.
Bull vs bear case
Upside drivers and key risks.
Valuation snapshot
Multiples vs history and peers.
Competitive moat
Defensibility and market position.
Management track record
Leadership and capital allocation history.
How it makes money
A short diagram of the business model.

Key Stats

Trading

Px/Chg 1D$3,630.00 / +0.14%
Avg Volume512.08K
Beta-0.09
Mkt Cap237.56B
FD Mkt Cap232.65B

Float

Shrs Out/Float65.44M / 25.51M
Short Float0.00%
Days to Cover0.00
Stock Repurchased$0.00

Current Valuation

EV261.16B
EV/EBITDA18.98
EV/Sales5.18
P/B2.84
P/S4.71
FCF Yield1.19%
ROE8.08%
ROA4.27%
Current Ratio2.27

Dividend

Cash$18.00
Yield55.73%
Yield (TTM)55.73%

Estimates

P/E35.12
Est P/E0.00
Est EPS35.91
Est PEG0.00

Valuation

Metric5Yr AvgJun '22Jun '23Jun '24Jun '25Oct '26
PRICE-BASED RATIOS
Price / Earnings82.48103.4179.9064.2143.23121.64
Price / Sales11.5615.3912.266.976.1817.00
Price / Book Value5.0410.775.283.023.302.84
Price / Free Cash Flow15.1199.87105.26-234.3120.5184.21
ENTERPRISE VALUE METRICS
Enterprise Value289,935.5340,374.7338,628.6236,678.8272,836.1261,159.1
Enterprise Value / Sales12.1515.6012.187.746.5418.69
Enterprise Value / EBITDA43.9952.8043.8026.9124.9671.49
Enterprise Value / EBIT58.6171.5159.2435.3533.1993.74

Financials

Full Financials
Millions JPY5Yr CAGR (%)Mar '22Mar '23Mar '24Mar '25Mar '26
INCOME STATEMENT
Revenue23.3%21,814.027,809.030,572.041,722.050,462.0
Gross Income24.2%11,631.014,770.017,099.022,469.027,688.0
EBITDA21%6,446.07,732.08,796.010,932.013,810.0
EBIT22.2%4,760.05,716.06,695.08,221.010,610.0
Net Income20.1%3,247.04,268.03,321.05,961.06,765.0
EPS (Diluted)17.3%54.0667.6850.4290.31102.46
BALANCE SHEET
Cash & ST Inv21.7%13,192.022,782.014,473.032,176.028,950.0
Total Assets26.4%62,053.098,567.0122,452.0143,020.0158,538.0
Total Liabilities24.6%30,886.034,038.051,762.064,540.074,351.0
Total Shareholder Equity28%31,170.064,539.070,590.078,022.083,677.0
CASH FLOW
Net Operating Cash Flow22.6%3,808.04,062.0-17.014,685.08,594.0
Cap Ex6.8%-446.0-822.0-893.0-2,119.0-581.0
Free Cash Flow24.3%3,362.03,240.0-910.012,566.08,013.0

Enterprise Value Bridge

Millions JPY26 Oct '26
Price (As of 26 Oct '26)3,660.00
Basic Shares65.44
Market Cap239,521.4
Diluted Shares66.03
Fully Diluted Shares Outstanding66.03
Fully Diluted Market Cap241,666.1
+Consolidated Debt52,046.0
−In-the-Money Convertible Debt—
+Capital Leases9,073.0
+Operating Leases—
−Cash & Equivalents-28,950.0
−Short-term Investments-
+Total Preferred-
−In-the-Money Convertible Preferred—
−Investments in Unconsolidated Subs—
+Non-Controlling Interest505.0
+Pension Liabilities—
Enterprise Value263,122.4

Related companies

BrightSpring Health Services, Inc.

BTSG US

Pro Medicus Ltd./ADR

PMCUF US

Hinge Health, Inc.

HNGE US

Alibaba Health Information Technology Limited/ADR

ALBBY US

Doximity, Inc.

DOCS US

Heartflow, Inc.

HTFL US

Privia Health Group, Inc.

PRVA US

Winning Health Technology Group Co., Ltd.

300253 CS

Indegene Limited

INDGN IB

Certara, Inc.

CERT US

Pennant Group, Inc.

PNTG US

U S Physical Therapy Inc /NV

USPH US

JMDC Inc. — Company Profile

JMDC Inc. is a Japanese corporation primarily focused on delivering analytical and statistical services for the medical sector. Its operations are structured across three principal divisions: Healthcare-Big Data, Telemedicine, and Dispensing Pharmacy Support. Within the Healthcare-Big Data segment, the company provides extensive big data solutions tailored for both the medical and life insurance industries. It also offers crucial support services to health insurance associations and local government health programs, develops a robust health data platform, and aids medical institutions. The Telemedicine division facilitates remote medical imaging interpretation through specialized matching services and ASP systems. Concurrently, its Dispensing Pharmacy Support segment develops and markets bespoke business management software specifically designed for dispensing pharmacies. JMDC serves a broad spectrum of clients, including health insurance providers, pharmaceutical manufacturers, life and general insurance companies, and research organizations. The company, established in 2002, maintains its corporate headquarters in Tokyo, Japan.

Sector
Healthcare
Industry
Medical - Healthcare Information Services
Exchange
JT
CEO
Ryo Noguchi
Headquarters
Tokyo, TY, JP
IPO Date
Dec 16, 2019
Employees
2,444
Website
www.jmdc.co.jp

Key Metrics

Price
$3630.00
Market Cap
$237.56B
Revenue (TTM)
$50.46B
Net Income (TTM)
$6.76B
EPS (TTM)
103.43
P/E (TTM)
35.12
P/B (TTM)
2.84
Dividend Yield
55.73%
ROE (TTM)
8.08%
ROA (TTM)
4.27%
Operating Margin
19.78%
Beta
-0.09

Dividends

Last Dividend
$18.00
Last Yield
0.56%

Summary

JMDC Inc. is a Japanese corporation primarily focused on delivering analytical and statistical services for the medical sector. Its operations are structured across three principal divisions: Healthcare-Big Data, Telemedicine, and Dispensing Pharmacy Support. Within the Healthcare-Big Data segment, the company provides extensive big data solutions tailored for both the medical and life insurance industries. It also offers crucial support services to health insurance associations and local government health programs, develops a robust health data platform, and aids medical institutions. The Telemedicine division facilitates remote medical imaging interpretation through specialized matching services and ASP systems. Concurrently, its Dispensing Pharmacy Support segment develops and markets bespoke business management software specifically designed for dispensing pharmacies. JMDC serves a broad spectrum of clients, including health insurance providers, pharmaceutical manufacturers, life and general insurance companies, and research organizations. The company, established in 2002, maintains its corporate headquarters in Tokyo, Japan.

Website
www.jmdc.co.jp
Location
Tokyo, TY, JP
Phone81 3 5733 5010
Employees2,444
CEORyo Noguchi
SectorHealthcare
IndustryMedical - Healthcare Information Services
IPO DateDec 16, 2019

Ask AI

Company overview
Business model, segments, and competition.
Peer comparison
Metrics vs closest competitors.
Guidance & outlook
Forward guidance and assumptions.
Bull vs bear case
Upside drivers and key risks.
Valuation snapshot
Multiples vs history and peers.
Competitive moat
Defensibility and market position.
Management track record
Leadership and capital allocation history.
How it makes money
A short diagram of the business model.

Key Stats

Trading

Px/Chg 1D$3,630.00 / +0.14%
Avg Volume512.08K
Beta-0.09
Mkt Cap237.56B
FD Mkt Cap232.65B

Float

Shrs Out/Float65.44M / 25.51M
Short Float0.00%
Days to Cover0.00
Stock Repurchased$0.00

Current Valuation

EV261.16B
EV/EBITDA18.98
EV/Sales5.18
P/B2.84
P/S4.71
FCF Yield1.19%
ROE8.08%
ROA4.27%
Current Ratio2.27

Dividend

Cash$18.00
Yield55.73%
Yield (TTM)55.73%

Estimates

P/E35.12
Est P/E0.00
Est EPS35.91
Est PEG0.00

Valuation

Metric5Yr AvgJun '22Jun '23Jun '24Jun '25Oct '26
PRICE-BASED RATIOS
Price / Earnings82.48103.4179.9064.2143.23121.64
Price / Sales11.5615.3912.266.976.1817.00
Price / Book Value5.0410.775.283.023.302.84
Price / Free Cash Flow15.1199.87105.26-234.3120.5184.21
ENTERPRISE VALUE METRICS
Enterprise Value289,935.5340,374.7338,628.6236,678.8272,836.1261,159.1
Enterprise Value / Sales12.1515.6012.187.746.5418.69
Enterprise Value / EBITDA43.9952.8043.8026.9124.9671.49
Enterprise Value / EBIT58.6171.5159.2435.3533.1993.74

Financials

Full Financials
Millions JPY5Yr CAGR (%)Mar '22Mar '23Mar '24Mar '25Mar '26
INCOME STATEMENT
Revenue23.3%21,814.027,809.030,572.041,722.050,462.0
Gross Income24.2%11,631.014,770.017,099.022,469.027,688.0
EBITDA21%6,446.07,732.08,796.010,932.013,810.0
EBIT22.2%4,760.05,716.06,695.08,221.010,610.0
Net Income20.1%3,247.04,268.03,321.05,961.06,765.0
EPS (Diluted)17.3%54.0667.6850.4290.31102.46
BALANCE SHEET
Cash & ST Inv21.7%13,192.022,782.014,473.032,176.028,950.0
Total Assets26.4%62,053.098,567.0122,452.0143,020.0158,538.0
Total Liabilities24.6%30,886.034,038.051,762.064,540.074,351.0
Total Shareholder Equity28%31,170.064,539.070,590.078,022.083,677.0
CASH FLOW
Net Operating Cash Flow22.6%3,808.04,062.0-17.014,685.08,594.0
Cap Ex6.8%-446.0-822.0-893.0-2,119.0-581.0
Free Cash Flow24.3%3,362.03,240.0-910.012,566.08,013.0

Enterprise Value Bridge

Millions JPY26 Oct '26
Price (As of 26 Oct '26)3,660.00
Basic Shares65.44
Market Cap239,521.4
Diluted Shares66.03
Fully Diluted Shares Outstanding66.03
Fully Diluted Market Cap241,666.1
+Consolidated Debt52,046.0
−In-the-Money Convertible Debt—
+Capital Leases9,073.0
+Operating Leases—
−Cash & Equivalents-28,950.0
−Short-term Investments-
+Total Preferred-
−In-the-Money Convertible Preferred—
−Investments in Unconsolidated Subs—
+Non-Controlling Interest505.0
+Pension Liabilities—
Enterprise Value263,122.4

Related companies

BrightSpring Health Services, Inc.

BTSG US

Pro Medicus Ltd./ADR

PMCUF US

Hinge Health, Inc.

HNGE US

Alibaba Health Information Technology Limited/ADR

ALBBY US

Doximity, Inc.

DOCS US

Heartflow, Inc.

HTFL US

Privia Health Group, Inc.

PRVA US

Winning Health Technology Group Co., Ltd.

300253 CS

Indegene Limited

INDGN IB

Certara, Inc.

CERT US

Pennant Group, Inc.

PNTG US

U S Physical Therapy Inc /NV

USPH US